These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30560011)

  • 1. The Receptor for Advanced Glycation Endproducts (RAGE) and Mediation of Inflammatory Neurodegeneration.
    Derk J; MacLean M; Juranek J; Schmidt AM
    J Alzheimers Dis Parkinsonism; 2018; 8(1):. PubMed ID: 30560011
    [No Abstract]   [Full Text] [Related]  

  • 2. All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses.
    Oczypok EA; Perkins TN; Oury TD
    Paediatr Respir Rev; 2017 Jun; 23():40-49. PubMed ID: 28416135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary AGEs and ALEs and risk to human health by their interaction with the receptor for advanced glycation endproducts (RAGE)--an introduction.
    Thornalley PJ
    Mol Nutr Food Res; 2007 Sep; 51(9):1107-10. PubMed ID: 17854008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings.
    Stern D; Yan SD; Yan SF; Schmidt AM
    Adv Drug Deliv Rev; 2002 Dec; 54(12):1615-25. PubMed ID: 12453678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.
    Stern DM; Yan SD; Yan SF; Schmidt AM
    Ageing Res Rev; 2002 Feb; 1(1):1-15. PubMed ID: 12039445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor for Advanced Glycation Endproducts (RAGE), Its Ligands, and Soluble RAGE: Potential Biomarkers for Diagnosis and Therapeutic Targets for Human Renal Diseases.
    Lee EJ; Park JH
    Genomics Inform; 2013 Dec; 11(4):224-9. PubMed ID: 24465234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Receptor of advanced glycation endproducts RAGE/AGER: an integrative view for clinical applications].
    Barbezier N; Tessier FJ; Chango A
    Ann Biol Clin (Paris); 2014; 72(6):669-80. PubMed ID: 25486663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of AGE-RAGE Signalling as a Modulator of Gut Permeability in Diabetes.
    Snelson M; Lucut E; Coughlan MT
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of hyperglycemia and acute pancreatitis on the receptor for advanced glycation endproducts.
    Zechner D; Sempert K; Genz B; Timm F; Bürtin F; Kroemer T; Butschkau A; Kuhla A; Vollmar B
    Int J Clin Exp Pathol; 2013; 6(10):2021-9. PubMed ID: 24133579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective.
    Bongarzone S; Savickas V; Luzi F; Gee AD
    J Med Chem; 2017 Sep; 60(17):7213-7232. PubMed ID: 28482155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening system of blocking agents of the receptor for advanced glycation endproducts in cells using fluorescence.
    Jung DH; Kim YS; Kim JS
    Biol Pharm Bull; 2012; 35(10):1826-30. PubMed ID: 23037172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.
    Lue LF; Yan SD; Stern DM; Walker DG
    Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):249-66. PubMed ID: 15975028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation endproducts: from precursors to RAGE: round and round we go.
    Ramasamy R; Yan SF; Schmidt AM
    Amino Acids; 2012 Apr; 42(4):1151-61. PubMed ID: 20957395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation endproducts and polysialylation affect the turnover of the neural cell adhesion molecule (NCAM) and the receptor for advanced glycation endproducts (RAGE).
    Frank F; Bezold V; Bork K; Rosenstock P; Scheffler J; Horstkorte R
    Biol Chem; 2019 Jan; 400(2):219-226. PubMed ID: 30138107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity.
    Teismann P; Sathe K; Bierhaus A; Leng L; Martin HL; Bucala R; Weigle B; Nawroth PP; Schulz JB
    Neurobiol Aging; 2012 Oct; 33(10):2478-90. PubMed ID: 22227007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Receptor for Advanced Glycation Endproducts Drives T Cell Survival and Inflammation in Type 1 Diabetes Mellitus.
    Durning SP; Preston-Hurlburt P; Clark PR; Xu D; Herold KC;
    J Immunol; 2016 Oct; 197(8):3076-3085. PubMed ID: 27655844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The receptor for advanced glycation endproducts (RAGE) decreases survival of tumor-bearing mice by enhancing the generation of lung metastasis-associated myeloid-derived suppressor cells.
    Wuren T; Huecksteadt T; Beck E; Warren K; Hoidal J; Ostrand-Rosenberg S; Sanders K
    Cell Immunol; 2021 Jul; 365():104379. PubMed ID: 34038758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between calcium, amyloid beta and the receptor for advanced glycation endproducts in Alzheimer's disease.
    Leclerc E; Sturchler E; Vetter SW; Heizmann CW
    Rev Neurosci; 2009; 20(2):95-110. PubMed ID: 19774788
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.